Parent and Adolescent Knowledge of HPV and Subsequent Vaccination

Human papillomavirus (HPV) vaccination coverage for adolescent females and males remains low in the United States. We conducted a 3-arm randomized controlled trial (RCT) conducted in middle and high schools in eastern Georgia from 2011-2013 to determine the effect of 2 educational interventions used to increase adolescent vaccination coverage for the 4 recommended adolescent vaccines: Tdap, MCV4, HPV and influenza. As part of this RCT, this article focuses on: 1) describing initiation and completion of HPV vaccine series among a diverse population of male and female adolescents; 2) assessing parental attitudes toward HPV vaccine; and 3) examining correlates of HPV vaccine series initiation and completion. Parental attitude score was the strongest predictor of HPV vaccine initiation among adolescents (adjusted odds ratio (aOR): 2.08; 95% confidence interval (CI): 1.80, 2.39). Other correlates that significantly predicted HPV series initiation were gender, study year, and intervention arm. Parental attitudes remained a significant predictor of receipt of 3 doses of HPV vaccine along with gender, race, school type and insurance type. This study demonstrates that positive parental attitudes are important predictors of HPV vaccination and critical to increasing coverage rates. Our findings suggest that more research is needed to understand how parental attitudes are developed and evolve over time.

Section: Discussionsupporting

confidence: 91%

Human papillomavirus vaccination among adolescents in Georgia

Underwood

Weiss

Gargano

et al. 2015

“…Furthermore, although parents of unvaccinated boys reported similar or greater agreement than parents of unvaccinated girls with statements about HPV vaccine safety and efficacy, they were also more likely to agree it is more important for girls to get HPV vaccine. Some prior research suggests parental knowledge about HPV and HPV vaccination is generally not associated with vaccine acceptability or vaccination initiation; 25,37 however, parental attitudes and beliefs related to HPV disease and vaccination are associated with acceptability and initiation. 18,25,26 Dorell et al found concerns about HPV vaccine safety and effectiveness were reported more often by parents who refused HPV vaccination for their adolescents than parents who delayed but did not refuse vaccination.…”

Section: ããmentioning

confidence: 98%

Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls

Lindley

Jeyarajah

Yankey

et al. 2016

Background/Objective: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. Previous research suggests some differences between male and female adolescents in correlates of vaccine receipt and reasons for non-vaccination; few studies examine both sexes together. This analysis assessed knowledge and attitudes related to HPV disease and vaccination, intention to vaccinate, and reasons for delayed vaccination or non-vaccination among parents of boys and girls 13-17 y old in 50 states, the District of Columbia, and selected local areas. Methods: National Immunization Survey-Teen 2013 data were analyzed and gender differences examined. Results: In this sample, adolescent boys were more likely than girls to be unvaccinated and less likely to have completed the HPV vaccination series (p < 0.005 for both). Parents of girls were more likely than parents of boys to report a provider recommendation for HPV vaccination (65.0% vs. 42.1%). Only 29% of girls' parents reported a provider recommendation to begin vaccination by 11-12 y old. Among unvaccinated teens, parental intention to vaccinate in the next 12 months did not differ by sex, but reasons for vaccination or nonvaccination did. Many parents do not know the recommended number of HPV doses. Conclusions: Gender differences in provider vaccination recommendations and reasons for vaccination might partially explain differential HPV uptake by male and female adolescents. Clinicians should offer strong recommendations for HPV vaccination at 11-12 y old for both girls and boys. To reduce missed opportunities, HPV vaccination should be presented in the context of, and given concurrently with, other routinely administered vaccines.

“…7,8 In Italy, the vaccination is currently recommended and provided free for girls aged 11 and 12 y, and only in few geographic areas also for men. Numerous studies in different countries have evaluated individuals' knowledge, attitudes, and behaviors toward the vaccination mainly among health care providers, [9][10][11] adolescents, [13][14][15][16] and women and men for themselves [17][18][19][20][21][22][23][24][25] or for their adolescent daughters [26][27][28] or sons. [29][30][31] Unfortunately all these issues among young males have only been studied to a limited extent.…”

Section: Introductionmentioning

confidence: 99%

Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy

Napolitano

Liguori

et al. 2016

This study assessed knowledge and attitudes about Human papillomavirus (HPV) and the relative vaccination and their determinants in a sample of young males. The survey was conducted between January and April 2015 among a sample of 1000 males aged between 14-24 y in the geographic area of Naples and Caserta, Italy. The 54.9% of the participants reported of having heard about the HPV infection. Those who were aware about the availability of the vaccine, who reported the first vaginal sexual encounter before the 18 y and at least at 18 y compared to those who had not had a complete sexual intercourse, who had undergone a health checkup in the last year, and who had received information about the HPV vaccine by physicians had a significant higher knowledge about the HPV infection. The 58.2% reported that they would be willing to receive the HPV vaccine. Those younger, who reported the first vaginal sexual encounter at least at 18 y, who agreed that male should receive the vaccine, who knew that both males and females can acquire the infection, and who agreed that the vaccine is an important preventive intervention, expressed more positive attitude toward willingness to receive the vaccine. More information about the HPV vaccine were required by those who agreed that the vaccine is an important preventive intervention, who reported the first vaginal sexual encounter at least at 18 y, who have had only one partner in the last year compared to students who had no partner, and who had received information about the vaccine by physicians. This study highlights a need for improved education of young males of the HPV infection and the associated diseases and about the benefit of the vaccination.